Cargando…

Polymorphisms in the cytotoxic T lymphocyte-associated protein-4 immune regulatory gene and their impact on inhibitor development in patients with hemophilia A

OBJECTIVE: The development of inhibitors against infused factor VIII represents the most severe complication of substitution therapy in hemophilia A (HA) patients. Data on risk factors for inhibitor formation in Iraqi Kurdish patients with HA are unavailable. This study aimed to evaluate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdulqader, Aveen M. Raouf, Mohammed, Ali Ibrahim, Rachid, Shwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833422/ https://www.ncbi.nlm.nih.gov/pubmed/31524022 http://dx.doi.org/10.1177/0300060519860329

Ejemplares similares

Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A
por: Abdulqader, Aveen M. Raouf, et al.
Publicado: (2020)

Application of Indirect Linkage Analysis for Carrier Detection of Hemophilia A in Kurdistan Region of Iraq: Usefulness of Intron 18 BclI T>A, Intron 19 HindIII C>T, and IVS7 nt27 G>A Markers
por: Abdulqader, Aveen M. Raouf, et al.
Publicado: (2019)

ABO Blood Groups and Thrombophilia Markers in Patients With Unstimulated Thrombosis in Kurdistan Region of Iraq
por: Mohammed, Ali Ibrahim, et al.
Publicado: (2020)

Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
por: Shapiro, Amy D., et al.
Publicado: (2022)

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A
por: Schep, Sarah J., et al.
Publicado: (2021)

The impact of inhibitors on the quality of life in patients with hemophilia
por: Haghpanah, Sezaneh, et al.
Publicado: (2023)

Pseudotumor of hemophilia of the thumb: Clinical Presentation
por: Khubrani, Abdullah M., et al.
Publicado: (2020)

A Case of Hemophilia
por: Sheehan, R. F.
Publicado: (1906)

Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone
por: Elsayh, Khalid Ibrahim, et al.
Publicado: (2022)

Immune tolerance induction in patients with severe hemophilia A with inhibitors
por: Ryu, Ji Eun, et al.
Publicado: (2015)

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)

Regulatory T Cells and IL-10 Independently Counterregulate Cytotoxic T Lymphocyte Responses Induced by Transcutaneous Immunization
por: Stein, Pamela, et al.
Publicado: (2011)

Regulatory T-Cells Suppress Cytotoxic T Lymphocyte Responses against Microglia
por: Chauhan, Priyanka, et al.
Publicado: (2022)

Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study
por: Halimeh, Susan, et al.
Publicado: (2013)

A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients
por: Fidancı, İnanç Değer, et al.
Publicado: (2014)

Quality of Life in Hemophilia Complicated by Inhibitors
por: Bastani, P, et al.
Publicado: (2012)

Escape or Fight: Inhibitors in Hemophilia A
por: Merlin, Simone, et al.
Publicado: (2020)

Molecular Mechanisms of Inhibitor Development in Hemophilia
por: Tieu, Paul, et al.
Publicado: (2020)

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
por: Fletcher, James, et al.
Publicado: (2022)

Measuring the impact of hemophilia on families: Development of the Hemophilia Family Impact Tool (H‐FIT)
por: Dover, Saunya, et al.
Publicado: (2021)

Measuring hemophilia caregiver burden: validation of the Hemophilia Caregiver Impact measure
por: Schwartz, Carolyn E., et al.
Publicado: (2017)

Editorial: Regulatory T lymphocytes in cancer immunity
por: Adeegbe, Dennis, et al.
Publicado: (2022)

Perioperative Management of Patients with Hemophilia during Spinal Surgery
por: Kobayashi, Kazuyoshi, et al.
Publicado: (2018)

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients
por: Sato, Y, et al.
Publicado: (2004)

p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy
por: Lu, Chunwan, et al.
Publicado: (2020)

Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A→G) and migraine
por: Lulli, P., et al.
Publicado: (2005)

On Column Binding a Real-Time Biosensor for β-lactam Antibiotics Quantification
por: Abdullah, Shahla M., et al.
Publicado: (2020)

Development of inhibitors in hemophilia A: An illustrated review
por: Jardim, Letícia Lemos, et al.
Publicado: (2020)

Costs of the management of hemophilia A with inhibitors in Spain
por: Bonanad, Santiago, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors Regulate K(+) Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients
por: Gawali, Vaibhavkumar S., et al.
Publicado: (2021)

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
por: Saba, Hussain I, et al.
Publicado: (2011)

Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer
por: Kaewkangsadan, Viriya, et al.
Publicado: (2016)

The Cytotoxic T Lymphocyte Antigen-4 +49A/G Single Nucleotide Polymorphism Association With Visceral Leishmaniasis
por: Hajilooi, Mehrdad, et al.
Publicado: (2014)

The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program
por: Owaidah, Tarek, et al.
Publicado: (2017)

Importance of immune response genes in hemophilia A
por: de Alencar, Josiane Bazzo, et al.
Publicado: (2013)

Physical and psychosocial challenges in adult hemophilia patients with inhibitors
por: duTreil, Sue
Publicado: (2014)

A Public Health Approach to the Prevention of Inhibitors in Hemophilia
por: Soucie, J. Michael, et al.
Publicado: (2014)

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors
por: Ju, Hee Young, et al.
Publicado: (2015)

Manual therapy in the treatment of patients with hemophilia B and inhibitor
por: Cuesta-Barriuso, Rubén, et al.
Publicado: (2018)

Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_4airsi5rcpfrg7hg6dijt1co1b